Self-amplifying non-coding rna for targeted gene knockdown
AssigneeThe Regents of the University of California
InventorsWilliam M. Gelbart, Charles M. Knobler, Feng Guo
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsWilliam M. Gelbart, Charles M. Knobler, Feng Guo
Estimating the term…
We describe the construction of a self-replicating form of microRNA (miRNA) and demonstrate its amplification and biological activity in cultured cells. In typical embodiments, a miRNA sequence of interest is flanked by self-cleaving ribozymes and added to RNAl of the Nodamura virus, which is directly translated to generate an RNA-dependent-RNA-polymerase that replicates it strongly along with the doubly-self-cleaving ribozyme cassette containing the miRNA. In the specific case of miR-34a flanked by Hammerhead and Tetrahymena ribozymes, BHK-21 cells transfected with the replicon form of this cassette are shown to generate up to one million copies/cell of the miRNA. The biological activity of this amplified miR-34a is demonstrated by the essentially complete apoptosis of cultured prostate cancer cells transfected with the replicon. More generally, we provide this self-amplifying form of miRNA as a means for restoring homeostatic levels of miRNA in cancer cells, as well as for targeting specific gene expression.
A composition of matter comprising a polynucleotide, wherein the polynucleotide comprises:
A composition of matter comprising a polynucleotide, wherein the polynucleotide comprises:
Dependencies are inferred from the claim text.